63819-85-2Relevant articles and documents
SUBSTITUTED PYRROLIDINE AMIDES III
-
Paragraph 0174-0175, (2020/07/25)
The invention relates to compounds according to general formula (I), which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.
Nitro as a novel zinc-binding group in the inhibition of carboxypeptidase A
Wang, Si-Hong,Wang, Shou-Feng,Xuan, Wei,Zeng, Zong-Hao,Jin, Jing-Yi,Ma, Jie,Tian, Guan Rong
, p. 3596 - 3601 (2008/12/20)
2-Substituted 3-nitropropanoic acids were designed and synthesized as inhibitors against carboxypeptidase A (CPA). (R)-2-Benzyl- 3-nitropropanoic acid showed a potent inhibition against CPA (Ki = 0.15 μM). X-ray crystallography discloses that t
Quinuclidine N-oxide: A potential replacement for HMPA
O'Neil, Ian A.,Lai, Justine Y. Q.,Wynn, Duncan
, p. 59 - 60 (2007/10/03)
The use of quinuclidine N-oxide as a replacement for HMPA is described.